← Eichor
Study identifier: NCT06413459 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis

Condition: Non-Tuberculous Mycobacterial Pneumonia · Cystic Fibrosis Lung  ·  Sponsor: Ospedale San Raffaele

PhaseN/A
Planned participants40
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

In this project the investigators aim to identify new biological markers by characterizing the response/inflammation associated with the development and progression of M. abscessus lung disease in patients suffering from cystic fibrosis with the aim of increasing current knowledge available on the development and progression of lung disease.

This description comes directly from the study's public registry record.

Talk to the study team

Nicola I Lorè, PhD  ·  +390226434902  ·  lore.nicolaivan@hsr.it

Always discuss trial participation with your own doctor first.

Locations (1)

Ospedale San RaffaeleMilan, MI, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06413459